NCT07069920View on ClinicalTrials.gov

To Evaluate the Efficacy and Safety of 'BRDE33-100' for the Temporary Correction of Moderate to Severe Nasolabial Folds

NAActive, not recruitingINTERVENTIONAL

Enrollment

128

Participants

Timeline

Start Date

November 14, 2024

Primary Completion Date

June 25, 2025

Study Completion Date

May 31, 2026

Conditions

Nasolabial Folds

Interventions

DEVICE

BRDE33-100

BRDE33-100 will be injected once at Visit 2 (Baseline).

DEVICE

Soonsoofill

Soonsoofill will be injected once at Visit 2 (Baseline).

Trial Locations (1)

26426

Name: Wonju severance Christian hospital, Wŏnju

All Listed Sponsors

lead

BRPharm Co., Ltd.

INDUSTRY

NCT07069920 - To Evaluate the Efficacy and Safety of 'BRDE33-100' for the Temporary Correction of Moderate to Severe Nasolabial Folds | Biotech Hunter | Biotech Hunter